Fasciola gigantica: Anthelmintic effect of the aqueous extract of Artocarpus lakoocha

Experimental Parasitology

Volumn 122, Issue 4, 2009, Pages 289-298

  Saowakon, Naruwan ^a   Tansatit, Tawewan ^a   Wanichanon, Chaitip ^a   Chanakul, Waraporn ^a   Reutrakul, Vichai ^a   Sobhon, Prasert ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anthelmintic drug; Artocarpus lakoocha; Fasciola gigantica; Tegument

Indexed keywords

2,4,3,5' TETRAHYDROXYSTILBENE; ARTOCARPUS LAKOOCHA EXTRACT; PLANT EXTRACT; STILBENE DERIVATIVE; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ARTICLE; ARTOCARPUS LAKOOCHA; BASEMENT MEMBRANE; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; FASCIOLA HEPATICA; HERB; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SWELLING; SYNCYTIUM; WORM TEGUMENT;

ANIMALS; ANTHELMINTICS; ARTOCARPUS; BENZIMIDAZOLES; CATTLE; FASCIOLA; LARVA; MICROSCOPY, ELECTRON, SCANNING; MOVEMENT; PLANT EXTRACTS; RANDOM ALLOCATION;

ARTOCARPUS LAKOOCHA; FASCIOLA GIGANTICA;

EID: 67449143202     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.04.011     Document Type: Article

References (35)

1. Andrabi S.A., Spina M.G., Lorenz P., Ebmeyer U., Wolf G., and Horn T.F.W. Oxyresveratrol (trans-2,3′,4,5′-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Research 1017 (2004) 98-107
2. Apinhasmit W., and Sobhon P. Opisthorchis viverrini: effect of praziquantel on the adult tegument. The Southeast Asian Journal of Tropical Medicine and Public Health 27 (1996) 304-311
3. Buchanan J.F., Fairweather I., Brennan G.P., Trudgett A., and Hoey E.M. Fasciola hepatica: Surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen'). Parasitology 126 (2003) 141-153
4. Charoenlarp P., Radomyos P., and Bunnag D. The optimum dose of Puag-Haad in the treatment of taeniasis. Journal of the Medical Association of Thailand 72 (1989) 71-73
5. Charoenlarp P., Radomyos P., and Harinasuta T. Treatment of taeniasis with Puag-Haad: a crude extract of Artocarpus lakoocha wood. The Southeast Asian Journal of Tropical Medicine and Public Health 12 (1981) 568-570
6. Chung K.O., Kim B.Y., Lee M.H., Kim Y.R., Chung H.Y., Park J.H., and Moon J.O. In-vitro and in vivo anti-inflammatory effect of oxyresveratrol from Morus alba L. The Journal of Pharmacy and Pharmacology 55 (2003) 1695-1700
7. Dangprasert T., Khawsuk W., Meepool A., Wanichanon C., Viyanant V., Upatham E.S., Wongratanacheevin S., and Sobhon P. Fasciola gigantica: surface topography of the adult tegument. Journal of Helminthology 75 (2001) 43-50
8. Gusel'nikova LM. The effect of certain fasciolicides on the tegument of Fasciola hepatica implanted under the skin on the back of white rats. Meditsinskaya Parazitologiya i Parazitarnye Bolezni 43 (1974) 214-217
9. Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. Journal Helminthology 79 (2005) 227-234
10. Fairweather I., and Boray J.C. Fasciolicides: efficacy, actions, resistance and its management. The Veterinary Journal 158 (1999) 81-112
11. Fairweather I., Holmes S.D., and Threadgold L.T. Fasciola hepatica: motility responses to fasciolicides in vitro. Experimental Parasitology 57 (1984) 209-244
12. Keiser J., Engels D., Büscher G., and Utzinger J. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opinion on Investigational Drugs 14 (2005) 1513-1526
13. Keiser J., Xiao S.H., Chollet J., Tanner M., and Utzinger J. Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini. Antimicrobial Agents and Chemotherapy 51 (2007) 1096-1098
14. Keiser J., Utzinger J., Vennerstrom J.L., Dong Y., Brennan G., and Fairweather I. Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica. Transactions of the Royal Society of Tropical Medicine and Hygiene 101 (2007) 1219-1222
15. Kiuchi F., Miyashita N., Tsuda Y., Kondo K., and Yoshimura H. Studies on crude drugs effective on visceral larva migrans. I. Identification of larvicidal principles in betel nuts. Chemical and Pharmaceutical Bulletin 35 (1987) 2880-2886
16. Likhitwitayawuid K., Sornsute A., Sritularak B., and Ploypradith P. Chemical transformations of oxyresveratrol (trans-2,4,3′,5′-tetrahydroxystilbene) into a potent tyrosinase inhibitor and a strong cytotoxic agent. Bioorganic & Medicinal Chemistry Letters 16 (2006) 5650-5653
17. Likhitwitayawuid K., Sritularak B., Benchanak K., Lipipun V., Mathew J., and Schinazi R.F. Phenolics with antiviral activity from Millettia erythrocalyx and Artocarpus lakoocha. Natural Product Research 19 (2005) 177-182
18. López-Abán J., Casanueva P., Nogal J., Arias M., Morrondo P., Diez-Baños P., Hillyer G.V., Martínez-Fernández A.R., and Muro A. Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD. Veterinary Parasitology 145 (2007) 287-296
19. Lorenz P., Roychowdhury S., Engelmann M., Wolf G., and Horn T.F.W. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: Effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 9 (2003) 64-76
20. McKinstry B., Fairweather I., Brennan G.P., and Forbes A.B. Fasciola hepatica: Tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax). Parasitology Research 91 (2003) 251-263
21. McManus D.P., and Dalton J.P. Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica. Parasitology 133 Suppl. 2 (2006) S43-S61
22. Meaney M., Fairweather I., Brennan G.P., McDowell L.S.L., and Forbes A.B. Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes. Parasitology Research 91 (2003) 238-250
23. Mongkolsuk S., Robertson A., and Towers R. 2,4,3′,5′-Tetrahydroxystilbene from Artocarpus lakoocha. Journal of the Chemical Society, Japan (1957) 2231-2233
24. Poopyruchpong N., Rungruangsak K., Nimmanpisut S., Panijpan B., and Ratanabanangkoon K. Some physico-chemical properties of 2,4,3′,5′-tetrahydroxystilbene. Journal of the Science Society of Thailand 4 (1978) 163-167
25. Rivera N., Ibarra F., Zepeda A., Fortoul T., Hernández A., Castillo R., and Cantó G. Tegumental surface changes in adult Fasciola hepatica following treatment in vitro and in vivo with an experimental fasciolicide. Parasitology Research 93 (2004) 283-286
26. Sexton J.L., Milner A.R., Panaccio M., Waddington J., Wijffels G., Chandler D., Thompson C., Wilson L., Spithill T.W., and Mitchell G.F. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep. The Journal of Immunology 145 (1990) 3905-3910
27. Sobhon P., Anantavara S., Dangprasert T., Viyanant V., Krailas D., Upatham E.S., Wanichanon C., and Kusamran T. Fasciola gigantica: studies of the tegument as a basis for the developments of immunodiagnosis and vaccine. The Southeast Asian Journal of Tropical Medicine and Public Health 29 (1998) 387-400
28. Sobhon P., Dangprasert T., Chuanchaiyakul S., Meepool A., Khawsuk W., Wanichanon C., Viyanant V., and Upatham E.S. Fasciola gigantica: ultrastructure of the adult tegument. Science Asia 26 (2000) 137-148
29. Spithill T.W., and Dalton J.P. Progress in development of liver fluke vaccines. Parasitology Today 14 (1998) 224-228
30. Stitt A.W., and Fairweather I. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex). Parasitology Research 79 (1993) 529-536
31. Sukhapesan V., Tuntasuvan D., Sarataphan N., and Sa-ngiamluksana S. A study on epidemiology of liver fluke infection in buffaloes. Thailand Journal Veterinary Medicine 20 (1990) 527-534
32. Wedrychowicz H., Kesik M., Kaliniak M., Kozak-Cieszczyk M., Jedlina-Panasiuk L., Jaros S., and Plucienniczak A. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke. Veterinary Parasitology 147 (2007) 77-88
33. Wilson L.R., Good R.T., Panaccio M., Wijffels G.L., Samdeman R.M., and Spithill T.W. Fasciola hepatica: characterization and cloning of the major cathepsin B protease secreted by newly excysted juvenile liver fluke. Experimental Parasitology 88 (1998) 85-94
34. Wiwanitkit V., Suwansaksri J., and Chaiyakhun Y. High prevalence of Fasciolopsis buski in an endemic area of liver fluke infection in Thailand. Medscape General Medicine 4 (2002) 6
35. Wongsawad C., Wongsawad P., Luangphai P., and Kumchoo K. In vitro effects of aqueous extract from Artocarpus takoocha Roxb on tegumental surface of Haplorchis taichui. The Southeast Asian Journal of Tropical Medicine and Public Health 36 Suppl. 4 (2005) 112-116